Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate
In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million
FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea
Group Chairmen Propose Adding Four Trials For High Priority Status
DCE Board Approves Support Contract Recompetition
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Insights from ASCO 2025: Real-world evidence drives clinical decision-making